Tuesday, 02 January 2024 12:17 GMT

Pentagon Approves Arms Sale to Taiwan


(MENAFN) The Pentagon has confirmed that it has authorized its first weapons sale to Taiwan since US President Donald Trump assumed office in January.

China, which regards the self-governing island as part of its territory, condemned the decision as a violation of its sovereignty.

The planned transaction will have Taipei allocate $330 million to procure spare components for the American-made aircraft it operates, according to a statement from the US Department of War on Thursday.

The acquisition is expected to assist Taiwan in “maintaining the operational readiness of the… fleet of F-16, C-130” and other aircraft, the statement added.

Karen Kuo, a spokeswoman for Taiwan’s presidential office, praised the approval, asserting that the “deepening of the Taiwan-US security partnership is an important cornerstone of peace and stability in the Indo-Pacific region.”

Taiwan’s Defense Ministry indicated that the sale of the US aircraft parts will “take effect” within a month.

During a briefing, Chinese Foreign Ministry spokesman Lin Jian stated that Beijing “deplores and opposes” American arms sales to Taiwan, which he said contravene China’s security interests and “send a gravely wrong signal to ‘Taiwan independence’ separatist forces.”

The Taiwan matter remains “the first red line that must not be crossed in China-US relations,” Lin emphasized.

Officially, the US adheres to the One-China policy, acknowledging that Taiwan, which has exercised de facto self-rule since 1949 but never formally declared independence from Beijing, is a part of China.

MENAFN16112025000045017167ID1110350105



MENAFN

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search